Roche Holdings Ltd ADR (RHHBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RHHBY | LLY | NVO | JNJ | MRK |
| Company | Roche Holdings Ltd ADR | Eli Lilly and Company | Novo Nordisk A/S ADR | Johnson & Johnson | Merck & Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NYSE | NYSE |
| Open | 32.5200 | 784.71 | 133.13 | 153.00 | 131.37 |
| High | 32.7800 | 786.48 | 133.67 | 154.38 | 131.78 |
| Low | 32.4000 | 770.14 | 132.48 | 152.33 | 130.79 |
| Last | 32.6500 | 771.12 | 133.04 | 154.28 | 130.88 |
| Change | +1.2500 | -15.90 | -1.62 | +1.61 | -0.85 |
| % Change | +3.98% | -2.02% | -1.20% | +1.05% | -0.65% |
| Volume | 5,301,300 | 2,299,600 | 2,894,400 | 7,590,900 | 5,518,300 |
| 20-Day Average Volume | 3,830,965 | 2,877,125 | 4,258,145 | 7,884,810 | 7,287,860 |
| Previous Close | 31.4000 | 787.02 | 134.66 | 152.67 | 131.73 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 30.5275 | 755.53 | 127.78 | 149.27 | 129.04 |
| 20-Day Raw Stochastic | 96.37% | 68.42% | 87.04% | 98.98% | 75.73% |
| 20-Day Relative Strength | 60.62% | 53.33% | 59.71% | 57.11% | 58.26% |
| Weighted Alpha | -16.29 | +72.03 | +61.21 | -3.33 | +19.27 |
| Today's Opinion | 56% Sell | 88% Buy | 88% Buy | 56% Sell | 100% Buy |
| Previous Opinion | 64% Sell | 88% Buy | 88% Buy | 64% Sell | 100% Buy |
| Last Month's Opinion | 100% Sell | 56% Buy | 56% Buy | 88% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.66% since 05/09/24 | -0.06% since 05/09/24 | +3.40% since 05/09/24 | +2.96% since 05/09/24 | +0.50% since 05/09/24 |
| Low | 30.0600 on 05/13/24 | 750.53 on 05/13/24 | 128.33 on 05/10/24 | 149.19 on 05/10/24 | 128.02 on 05/13/24 |
| High | 32.7800 on 05/16/24 | 787.66 on 05/15/24 | 134.79 on 05/15/24 | 154.38 on 05/16/24 | 131.96 on 05/15/24 |
| 1-Month | |||||
| %Chg | +8.01% since 04/16/24 | +3.26% since 04/16/24 | +7.77% since 04/16/24 | +6.81% since 04/16/24 | +4.65% since 04/16/24 |
| Low | 29.2000 on 05/02/24 | 718.30 on 04/25/24 | 121.29 on 05/03/24 | 143.13 on 04/18/24 | 124.50 on 04/18/24 |
| High | 32.7800 on 05/16/24 | 795.50 on 04/30/24 | 134.79 on 05/15/24 | 154.38 on 05/16/24 | 132.80 on 04/25/24 |
| 3-Month | |||||
| %Chg | +1.15% since 02/16/24 | -1.40% since 02/16/24 | +7.28% since 02/16/24 | -1.45% since 02/16/24 | +2.42% since 02/16/24 |
| Low | 29.2000 on 05/02/24 | 718.30 on 04/25/24 | 118.30 on 02/21/24 | 143.13 on 04/18/24 | 119.23 on 03/15/24 |
| High | 35.2100 on 03/12/24 | 800.78 on 03/04/24 | 138.28 on 03/07/24 | 163.11 on 03/12/24 | 133.10 on 03/27/24 |
| 6-Month | |||||
| %Chg | -1.95% since 11/16/23 | +30.98% since 11/16/23 | +33.67% since 11/16/23 | +2.78% since 11/16/23 | +28.33% since 11/16/23 |
| Low | 29.2000 on 05/02/24 | 561.65 on 12/15/23 | 94.73 on 12/11/23 | 143.13 on 04/18/24 | 99.80 on 11/29/23 |
| High | 37.4900 on 01/04/24 | 800.78 on 03/04/24 | 138.28 on 03/07/24 | 163.58 on 01/22/24 | 133.10 on 03/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 214,462,000 | 747,987,776 | 604,291,136 | 367,427,680 | 333,646,528 |
| Shares Outstanding, K | 6,830,000 | 950,405 | 4,487,532 | 2,406,679 | 2,532,806 |
| Annual Sales | 67,325,230,000 | 34,124,100,000 | 33,724,300,000 | 85,159,000,000 | 60,115,000,000 |
| Annual Net Income | 12,807,620,000 | 5,240,400,000 | 12,150,770,000 | 35,153,000,000 | 365,000,000 |
| Last Quarter Sales | N/A | 8,768,000,000 | 9,514,810,000 | 21,383,000,000 | 15,775,000,000 |
| Last Quarter Net Income | N/A | 2,242,900,000 | 3,699,260,000 | 3,255,000,000 | 4,762,000,000 |
| 60-Month Beta | 0.41 | 0.37 | 0.43 | 0.55 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/30/24 | 0.83 on 05/02/24 | 2.71 on 04/16/24 | 2.07 on 04/25/24 |
| Latest Earnings Date | 02/01/24 | 04/30/24 | 05/02/24 | 04/16/24 | 04/25/24 |
| Most Recent Dividend | 0.847 on 03/14/24 | 1.300 on 05/15/24 | 0.663 on 03/22/24 | 1.190 on 02/16/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | 03/14/24 | 05/15/24 | 03/22/24 | 05/20/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 104.94 | 45.83 | 14.47 | 59.29 |